Keeping the Patient in the Center in AMD Care

 

Participate Now

The first part of this CME Outfitters Snack series on overcoming the challenges of prior authorization when treating patients with AMD features expert faculty discussing how to implement patient-centric care models that incorporate shared decision-making, which is imperative to educating patients on the benefits and risks of FDA-approved and off-label agents for the treatment of AMD.

Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication

 

Participate Now

In order to decrease the burden of PA for AMD treatments, the second module of this CME Outfitters Snack series aims to provide learners with strategies to improve documentation and establish clear communication with the payer to minimize treatment delays.

Honing in on the Appeal Process to Improve Access to Anti-VEGF Therapy for Patients with AMD

 

Participate Now

Step therapy requirements have limited patient access to FDA-approved, anti-VEGF agents for the treatment of AMD. Prior authorization requests for these therapies are commonly denied. Hence, it is important that clinicians be aware of the approaches to overcome these barriers and implement systemic and clinically supported appeals that ensure uninterrupted anti-VEGF therapy for patients with AMD. In the third module of this CME Outfitters Snack series, expert faculty focus on developing and implementing strategies for appeals in order to reduce treatment delays.

Zooming in on the Education and Empowerment of Patients in AMD Care

 

Participate Now

The final module of this CME Outfitters Snack series describes step therapy policies and their implications for the patient, with the goal of educating clinicians on the increased risk of these policies, including the possibility of increased medical costs and worsening of the disease, so that they can pass this knowledge on to their patients with AMD and work together to navigate through the PA process.